Context. Asynchronous messaging is increasingly used to support human–machine interactions, generally implemented through chatbots. Such virtual entities assist the users in activities of different kinds (e.g., work, leisure, and health-related) and are becoming ingrained into humans’ habits due to factors including (i) the availability of mobile devices such as smartphones and tablets, (ii) the increasingly engaging nature of chatbot interactions, (iii) the release of dedicated APIs from messaging platforms, and (iv) increasingly complex AI-based mechanisms to power the bots’ behaviors. Nevertheless, most of the modern chatbots rely on state machines (implementing conversational rules) and one-fits-all approaches, neglecting personalization, data-stream privacy management, multi-topic management/interconnection, and multimodal interactions. Objective. This work addresses the challenges above through an agent-based framework for chatbot development named EREBOTS. Methods. The foundations of the framework are based on the implementation of (i) multi-front-end connectors and interfaces (i.e., Telegram, dedicated App, and web interface), (ii) enabling the configuration of multi-scenario behaviors (i.e., preventive physical conditioning, smoking cessation, and support for breast-cancer survivors), (iii) online learning, (iv) personalized conversations and recommendations (i.e., mood boost, anti-craving persuasion, and balance-preserving physical exercises), and (v) responsive multi-device monitoring interface (i.e., doctor and admin). Results. EREBOTS has been tested in the context of physical balance preservation in social confinement times (due to the ongoing pandemic). Thirteen individuals characterized by diverse age, gender, and country distribution have actively participated in the experimentation, reporting advancements in the physical balance and overall satisfaction of the interaction and exercises’ variety they have been proposed.

Personalized support and assistance are essential for cancer survivors, given the physical and psychological consequences they have to suffer after all the treatments and conditions associated with this illness. Digital assistive technologies have proved to be effective in enhancing the quality of life of cancer survivors, for instance, through physical exercise monitoring and recommendation or emotional support and prediction. To maximize the efficacy of these techniques, it is challenging to develop accurate models of patient trajectories, which are typically fed with information acquired from retrospective datasets. This paper presents a Machine Learning-based survival model embedded in a clinical decision system architecture for predicting cancer survivors' trajectories. The proposed architecture of the system, named PERSIST, integrates the enrichment and pre-processing of clinical datasets coming from different sources and the development of clinical decision support modules. Moreover, the model includes detecting high-risk markers, which have been evaluated in terms of performance using both a third-party dataset of breast cancer patients and a retrospective dataset collected in the context of the PERSIST clinical study.

Background: Despite the advancement in eXplainable Artificial Intelligence, the explanations provided by model-agnostic predictors still call for improvements (i.e., lack of accurate descriptions of predictors’ behaviors). Contribution: We present a tool for Deep Explanations and Rule Extraction (DEXiRE) to approximate rules for Deep Learning models with any number of hidden layers. Methodology: DEXiRE proposes the binarization of neural networks to induce Boolean functions in the hidden layers, generating as many intermediate rule sets. A rule set is inducted between the first hidden layer and the input layer. Finally, the complete rule set is obtained using inverse substitution on intermediate rule sets and first-layer rules. Statistical tests and satisfiability algorithms reduce the final rule set’s size and complexity (filtering redundant, inconsistent, and non-frequent rules). DEXiRE has been tested in binary and multiclass classifications with six datasets having different structures and models. Results: The performance is consistent (in terms of accuracy, fidelity, and rule length) with respect to the state-of-the-art rule extractors (i.e., ECLAIRE). Moreover, compared with ECLAIRE, DEXiRE has generated shorter rules (i.e., up to $74\%$ fewer terms) and has shortened the execution time (improving up to $197\%$ in the best-case scenario). Conclusions: DEXiRE can be applied for binary and multiclass classification of deep learning predictors with any number of hidden layers. Moreover, DEXiRE can identify the activation pattern per class and use it to reduce the search space for rule extractors (pruning irrelevant/redundant neurons)—shorter rules and execution times with respect to ECLAIRE.

Cancer survivors face numerous challenges, and digital health interventions can empower them by enhancing self-efficacy and patient activation. This prospective study aimed to assess the impact of a mHealth app on self-efficacy and patient activation in 166 breast and colorectal cancer survivors. Participants received a smart bracelet and used the app to access personalized care plans. Data were collected at baseline and follow-ups, including patient-reported outcomes and clinician feedback. The study demonstrated positive impacts on self-efficacy and patient activation. The overall trial retention rate was 75.3%. Participants reported high levels of activation (PAM levels 1–3: P = 1.0; level 4: P = 0.65) and expressed a willingness to stay informed about their disease (CASE-Cancer factor 1: P = 0.98; factor 2: P = 0.66; factor 3: P = 0.25). Usability of the app improved, with an increase in participants rating the system as having excellent usability (from 14.82% to 22.22%). Additional qualitative analysis revealed positive experiences from both patients and clinicians. This paper contributes significantly to cancer survivorship care by providing personalized care plans tailored to individual needs. The PERSIST platform shows promise in improving patient outcomes and enhancing self-management abilities in cancer survivors. Further research with larger and more diverse populations is needed to establish its effectiveness.

In the past decades, the incidence rate of cancer has steadily risen. Although advances in early and accurate detection have increased cancer survival chances, these patients must cope with physical and psychological sequelae. The lack of personalized support and assistance after discharge may lead to a rapid diminution of their physical abilities, cognitive impairment, and reduced quality of life. This paper proposes a personalized support system for cancer survivors based on a cohort and trajectory analysis (CTA) module integrated within an agent-based personalized chatbot named EREBOTS. The CTA module relies on survival estimation models, machine learning, and deep learning techniques. It provides clinicians with supporting evidence for choosing a personalized treatment, while allowing patients to benefit from tailored suggestions adapted to their conditions and trajectories. The development of the CTA within the EREBOTS framework enables to effectively evaluate the significance of prognostic variables, detect patient’s high-risk markers, and support treatment decisions.